Hudson Bay Capital Management’s AbbVie ABBV Stock Holding History

Hudson Bay Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,300	Closed	-$1.17M	–	1202
2025 Q2	$1.17M	Sell	6,300 -58,700	-90%	-$10.9M	﹤0.01%	927
2025 Q1	$13.6M	Buy	65,000 +37,000	+132%	+$7.19M	0.04%	329
2024 Q4	$4.98M	Sell	28,000 -101,600	-78%	-$18.7M	0.02%	505
2024 Q3	$25.6M	Buy	+129,600	New	+$24.2M	0.1%	141
2017 Q2	–	Sell	-65,000	Closed	-$4.24M	–	512
2017 Q1	$4.24M	Sell	65,000 -94,500	-59%	-$5.94M	0.06%	302
2016 Q4	$9.99M	Buy	+159,500	New	+$9.74M	0.21%	105
2016 Q3	–	Sell	-160,000	Closed	-$9.91M	–	426
2016 Q2	$9.91M	Buy	+160,000	New	+$9.75M	0.31%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hudson Bay Capital Management's ABBV Position: Q2 2026 in Review

Hudson Bay Capital Management increased its AbbVie (ABBV) stake by 1,911% in Q2 2026, buying an estimated $82.3M and bringing the position to 402,440 shares worth $101M. The position accounts for 0.28% of the portfolio, ranked #83.

Hudson Bay Capital Management first reported a position in ABBV in Q3 2014 and has held it in 16 quarters since. The position peaked at $136M in Q1 2025. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hudson Bay Capital Management held 402,440 shares of AbbVie worth $101M as of Q2 2026.
Hudson Bay Capital Management bought 382,430 AbbVie shares in Q2 2026, an estimated $82.3M.
AbbVie made up 0.28% of Hudson Bay Capital Management's portfolio in Q2 2026, its #83 holding.
Hudson Bay Capital Management first reported a position in AbbVie in Q3 2014 and has held it in 16 quarters since.
Hudson Bay Capital Management's AbbVie position peaked at $136M in Q1 2025.
4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.